Lowering Barriers to R&D Innovation
We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.
Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles.
Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.
With the launch of our Interactive Project Portfolio Platform (IP3) we are embracing a new level of openness, access, and transparency around our idea-to-project process. The platform is open to the public to submit new ideas, comment and vote on proposed ideas, and monitor the progress of our projects.
Drug Discovery World wants to know and has asked the Pistoia Alliance to submit an article next month on this subject. And while we have some ideas already, we’d love to open this question to the floor. What do you see as the obstacles to innovation in the pharmaceutical industry?
The Pistoia Alliance was pleased to collaborate with the Innovative Medicines Initiative (IMI), Virtual Physiological Human (VPH) Network of Excellence, and Computational Modeling in Biology Network (COMBINE) communities to hold a biomedical data and model interoperability workshop on 28-29 March 2011.